Showing codes J3247 (Injection, secukinumab, intravenous, 1 mg) — J3372 (Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg)

J3247 - Inj secukinumab intrav 1mg
Long description: Injection, secukinumab, intravenous, 1 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3250 - Trimethobenzamide hcl inj
Long description: Injection, trimethobenzamide hcl, up to 200 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3260 - Tobramycin sulfate injection
Long description: Injection, tobramycin sulfate, up to 80 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3262 - Tocilizumab injection
Long description: Injection, tocilizumab, 1 mg
Code added date: 20110101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3263 - Inj, toripalimab-tpzi, 1 mg
Long description: Injection, toripalimab-tpzi, 1 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3265 - Injection torsemide 10 mg/ml
Long description: Injection, torsemide, 10 mg/ml
Code added date: 19960101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3280 - Thiethylperazine maleate inj
Long description: Injection, thiethylperazine maleate, up to 10 mg
Code added date: 19820101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3285 - Treprostinil injection
Long description: Injection, treprostinil, 1 mg
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3290 - Inj, tranexamic acid 5 mg
Long description: Injection, tranexamic acid, 5 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J3291 - Tranexamic acid in sod chlor
Long description: Injection, tranexamic acid in sodium chloride, 5 mg
Code added date: 20260101.
Code effective date: 20260101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J3299 - Inj xipere 1 mg
Long description: Injection, triamcinolone acetonide (xipere), 1 mg
Code added date: 20220701.
Code effective date: 20220701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3300 - Triamcinolone a inj prs-free
Long description: Injection, triamcinolone acetonide, preservative free, 1 mg
Code added date: 20090101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3301 - Triamcinolone acet inj nos
Long description: Injection, triamcinolone acetonide, not otherwise specified, 10 mg
Code added date: 19910101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3302 - Triamcinolone diacetate inj
Long description: Injection, triamcinolone diacetate, per 5 mg
Code added date: 19910101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3303 - Triamcinolone hexacetonl inj
Long description: Injection, triamcinolone hexacetonide, per 5 mg
Code added date: 19910101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3304 - Inj triamcinolone ace xr 1mg
Long description: Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3305 - Inj trimetrexate glucoronate
Long description: Injection, trimetrexate glucuronate, per 25 mg
Code added date: 19960101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3310 - Perphenazine injeciton
Long description: Injection, perphenazine, up to 5 mg
Code added date: 19820101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3315 - Triptorelin pamoate
Long description: Injection, triptorelin pamoate, 3.75 mg
Code added date: 20030101.
Code effective date: 20030101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3316 - Inj., triptorelin xr 3.75 mg
Long description: Injection, triptorelin, extended-release, 3.75 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3320 - Spectinomycn di-hcl inj
Long description: Injection, spectinomycin dihydrochloride, up to 2 gm
Code added date: 19820101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3350 - Urea injection
Long description: Injection, urea, up to 40 gm
Code added date: 19860101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3355 - Urofollitropin, 75 iu
Long description: Injection, urofollitropin, 75 iu
Code added date: 20060101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3357 - Ustekinumab sub cu inj, 1 mg
Long description: Ustekinumab, for subcutaneous injection, 1 mg
Code added date: 20110101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3358 - Ustekinumab, iv inject, 1 mg
Long description: Ustekinumab, for intravenous injection, 1 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3360 - Diazepam injection
Long description: Injection, diazepam, up to 5 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3364 - Urokinase 5000 iu injection
Long description: Injection, urokinase, 5000 iu vial
Code added date: 19930101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3365 - Urokinase 250,000 iu inj
Long description: Injection, iv, urokinase, 250,000 i.u. vial
Code added date: 19920101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3370 - Vancomycin hcl injection
Long description: Injection, vancomycin hcl, 500 mg
Code added date: 19860101.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3371 - Inj, vancomycin hcl (mylan)
Long description: Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
Code added date: 20230101.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3372 - Inj, vancomycin hcl (xellia)
Long description: Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg
Code added date: 20230101.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF